| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6095464 | Gastroenterology | 2014 | 8 Pages |
Abstract
In a nested case-control analysis of a UK population-based cohort, statin use was inversely associated with histologic subtypes of esophageal cancer. Randomized controlled trials are warranted to determine whether statins have chemopreventive effects in high-risk groups.
Keywords
National cancer registryGPRDEACNSAIDGERDPPIESCCHMG-CoAIQRNCREsophageal adenocarcinomagastroesophageal reflux diseaseTumornonsteroidal anti-inflammatory drugbody mass indexBMIconfidence intervalinterquartile rangeEsophagusProton pump inhibitorodds ratioGeneral Practice Research DatabaseSquamous cell carcinomaEsophageal squamous cell carcinomaEsophageal carcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Leo Alexandre, Allan B. Clark, Hina Y. Bhutta, Sean Holt, Michael P.N. Lewis, Andrew R. Hart,